These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24342913)

  • 41. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography.
    Lyshchik A; Fleischer AC; Huamani J; Hallahan DE; Brissova M; Gore JC
    J Ultrasound Med; 2007 Nov; 26(11):1575-86. PubMed ID: 17957052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft.
    Sugimoto K; Moriyasu F; Negishi Y; Hamano N; Oshiro H; Rognin NG; Yoshida T; Kamiyama N; Aramaki Y; Imai Y
    J Ultrasound Med; 2012 Dec; 31(12):1909-16. PubMed ID: 23197543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase shift variance imaging - a new technique for destructive microbubble imaging.
    Siepmann M; Fokong S; Mienkina M; Lederle W; Kiessling F; Gätjens J; Schmitz G
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 May; 60(5):909-23. PubMed ID: 23661125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis.
    Pillai R; Marinelli ER; Fan H; Nanjappan P; Song B; von Wronski MA; Cherkaoui S; Tardy I; Pochon S; Schneider M; Nunn AD; Swenson RE
    Bioconjug Chem; 2010 Mar; 21(3):556-62. PubMed ID: 20170116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improving sensitivity in ultrasound molecular imaging by tailoring contrast agent size distribution: in vivo studies.
    Streeter JE; Gessner R; Miles I; Dayton PA
    Mol Imaging; 2010 Apr; 9(2):87-95. PubMed ID: 20236606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
    Unnikrishnan S; Klibanov AL
    AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
    Weller GE; Wong MK; Modzelewski RA; Lu E; Klibanov AL; Wagner WR; Villanueva FS
    Cancer Res; 2005 Jan; 65(2):533-9. PubMed ID: 15695396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics.
    Kiessling F; Fokong S; Koczera P; Lederle W; Lammers T
    J Nucl Med; 2012 Mar; 53(3):345-8. PubMed ID: 22393225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular evaluation of thrombosis using X-ray phase contrast imaging with microbubbles targeted to P-selectin in mice.
    Tang R; Chai WM; Yan F; Yang GY; Chen KM
    Eur Radiol; 2016 Sep; 26(9):3253-61. PubMed ID: 26628067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver dysplasia: US molecular imaging with targeted contrast agent enables early assessment.
    Grouls C; Hatting M; Rix A; Pochon S; Lederle W; Tardy I; Kuhl CK; Trautwein C; Kiessling F; Palmowski M
    Radiology; 2013 May; 267(2):487-95. PubMed ID: 23360735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.
    Zhang H; Ingham ES; Gagnon MK; Mahakian LM; Liu J; Foiret JL; Willmann JK; Ferrara KW
    Biomaterials; 2017 Feb; 118():63-73. PubMed ID: 27940383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial adhesion of targeted microbubbles in both small and great vessels using ultrasound radiation force.
    Liu J; Zhang P; Liu P; Zhao Y; Gao S; Tan K; Liu Z
    Mol Imaging; 2012 Feb; 11(1):58-66. PubMed ID: 22418028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of binding capability of targeted KDR ultrasound contrast agent in vitro for evaluating endometrial receptivity].
    Liu H; Han X; Yang L; Ji L; Li S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1308-11. PubMed ID: 24067209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.
    Xuan JW; Bygrave M; Valiyeva F; Moussa M; Izawa JI; Bauman GS; Klibanov A; Wang F; Greenberg NM; Fenster A
    Mol Imaging; 2009; 8(4):209-20. PubMed ID: 19728975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific targeting of human inflamed endothelium and in situ vascular tissue transfection by the use of ultrasound contrast agents.
    Barreiro O; Aguilar RJ; Tejera E; Megías D; de Torres-Alba F; Evangelista A; Sánchez-Madrid F
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):997-1005. PubMed ID: 19679288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
    Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
    Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.